Array BioPharma, Inc. (ARRY) To Present At The Wells Fargo Securities 2014 Healthcare Conference  
6/12/2014 7:46:28 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOULDER, Colo., June 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities 2014 Healthcare Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Array BioPharma.


Wells Fargo Securities 2014 Healthcare Conference


Ron Squarer, Chief Executive Officer


Wednesday, June 18, 2014


8:20 a.m. Eastern Time


InterContinental Hotel, Boston, MA


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.


Logo -

SOURCE Array BioPharma Inc.

Help employers find you! Check out all the jobs and post your resume.